Yangmu Huang is a global health researcher at Peking University and a visiting scholar at the Institute of Development Studies (IDS). Her work focuses on end-to-end pathways that connect health innovation with equitable access across major health technologies, including vaccines and medical countermeasures, antimicrobial and neglected-disease products, nutrition interventions, and evidence-informed traditional medicine applications. She studies demand-driven R&D priority setting, R&D governance and coordination models that improve efficiency and accelerate development; she examines regulatory optimization and harmonization, manufacturing and supply capacity, and health-system readiness to reduce barriers to affordability, availability, and equitable delivery. She also applies generative AI to strengthen evidence synthesis and decision support for global health policy, with a focus on translating innovation into measurable, scalable, and sustainable health impact.

Dr. Huang has led more than 30 research grants supported by the National Natural Science Foundation of China, national ministries, and United Nations agencies, and has been selected for China’s National Young Talent Program. She has authored or co-authored over 80 scientific publications, including work in journals in the Lancet and BMJ portfolios. Beyond academia, she serves as a technical advisor to Chinese government ministries and consults for organizations such as WHO, UNICEF, and Gates Foundation. Through policy engagement and field-based collaboration with partners in more than 30 countries, she works to strengthen equitable R&D and delivery of global health public goods while advancing China’s contributions to global health.